BRWA
OSIR

B. Riley Wealth Advisors’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

B. Riley Wealth Advisors’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-6
Closed – – 2719
2014
Q4 		$0 Buy
+6
New +$80 ﹤0.01% 3858
2014
Q3 		– Sell
-143
Closed -$2.24K – 2530
2014
Q2 		$2.24K Buy
+143
New +$2.1K ﹤0.01% 2212

Other funds holding OSIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VCM
Venator Capital Management Toronto, Ontario, Canada $48.7M AUM 87.97% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

B. Riley Wealth Advisors's OSIR Position: Q1 2015 in Review

B. Riley Wealth Advisors sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q1 2015, closing a stake of 6 shares.

B. Riley Wealth Advisors first reported a position in OSIR in Q2 2014 and held it in 2 quarters. The position peaked at $2.24K in Q2 2014. 83 funds tracked by Wall St. Rank hold OSIR as of Q1 2015.

  • B. Riley Wealth Advisors reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q1 2015 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 6 Osiris Therapeutics, Inc. Common Stock shares in Q1 2015.
  • B. Riley Wealth Advisors first reported a position in Osiris Therapeutics, Inc. Common Stock in Q2 2014 and held it in 2 quarters.
  • B. Riley Wealth Advisors's Osiris Therapeutics, Inc. Common Stock position peaked at $2.24K in Q2 2014.
  • 83 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q1 2015.

Based on B. Riley Wealth Advisors's 13F filing for Q1 2015, filed 14 May 2015.